Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

5 Top Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/14/12 - 11:19 am
Tags:
Bristol-Myers Squibb, JNJ, Eli Lilly, Pfizer, Merck
Why Is Eli Lilly Climbing?
Motley Fool
Sun, 10/14/12 - 11:09 am
Tags:
Eli Lilly
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Tags:
Eli Lilly, Valeant Pharmaceuticals, Lexicon Pharmaceuticals, Sarepta Therapeutics, Amarin, NPS Pharmaceuticals, Aeterna Zentaris
Another Prospective Alzheimer's Trial
Seeking Alpha
Sat, 10/13/12 - 12:23 pm
Tags:
solanezumab, Eli Lilly, LY2886721, gantenerumab, Roche
Skepticism On Eli Lilly's Alzheimer's Drug (video)
Forbes
Sat, 10/13/12 - 12:21 pm
Tags:
solanezumab, Eli Lilly
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thu, 10/11/12 - 11:39 am
Tags:
Bristol-Myers Squibb, Pfizer, Sanofi, Eli Lilly, AstraZeneca
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Tags:
Alzheimer's disease, Eisai, Forest Labs, JNJ, Pfizer, Eli Lilly, Roche
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wed, 10/10/12 - 11:37 am
Tags:
Eli Lilly, AstraZeneca, GSK, JNJ, Merck, Pfizer
Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial
Bloomberg
Wed, 10/10/12 - 11:32 am
Tags:
Roche, Alzheimer's disease, Eli Lilly, solanezumab, gantenerumab
Lilly's Solanezumab: Did It Actually Work?
Seeking Alpha
Tue, 10/9/12 - 10:00 am
Tags:
Eli Lilly, solanezumab, Alzheimer's disease
New Promising Data Released on Lilly Alzheimer's Drug
WSJ Online
Tue, 10/9/12 - 09:52 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Mon, 10/8/12 - 12:53 pm
Tags:
Eli Lilly, diabetes, Boehringer Ingelheim, Amylin, LY2605541, GLP-1 agonist, SGLT2 inhibitor
Scientists plan to detail research on potential Alzheimer's treatments from Eli Lilly, Pfizer
Yahoo/AP
Mon, 10/8/12 - 10:38 am
Tags:
Eli Lilly, Alzheimer's disease, Pfizer, bapineuzumab, solanezumab
Investors, Take A Look At This Global Pharmaceutical Company
Motley Fool
Sat, 10/6/12 - 11:44 am
Tags:
Eli Lilly
Big Pharma to benefit from growth in diabetes: S&P
Marketwatch
Fri, 10/5/12 - 11:18 am
Tags:
diabetes, Big Pharma, Eli Lilly, Merck, Bristol-Myers Squibb
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Tags:
Celgene, JNJ, Bristol-Myers Squibb, Roche, ONYX Pharmaceuticals, Abraxane, Eli Lilly
[video]Is This Big Pharma Going Shopping?
Motley Fool
Wed, 10/3/12 - 12:38 pm
Tags:
M&A, AstraZeneca, Abbott Labs, Eli Lilly
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
Tags:
patents, Bristol-Myers Squibb, Amylin, AstraZeneca, Novo Nordisk, Eli Lilly, Merck
7 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 09/29/12 - 12:56 pm
Tags:
Novartis, Eli Lilly, Merck, Pfizer, Acura Pharmaceuticals, SciClone Pharmaceuticals, Lannett
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
Yahoo/PR Newswire
Sat, 09/29/12 - 12:25 pm
Tags:
ramucirumab, lung cancer, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.